Healthcare ETFs Are Looking Up: Here's Why Sanghamitra Saha Aug 19, 2026 Healthcare ETFs are hitting 52-week highs as earnings improve, dealmaking accelerates, FDA approvals stay strong and investors seek defensive growth.
Will Generic Drug Tariffs Impact Pharma ETFs? Zacks Equity Research Jul 30, 2026 New U.S. tariffs on generic drugs could pressure drugmakers and influence pharmaceutical ETFs. Here's what investors should watch.
ETFs to Buy Post JNJ's Q2 Earnings Beat & Bullish 2026 Outlook Aparajita Dutta Jul 23, 2026 Johnson & Johnson's Q2 beat and strong pharma momentum are raising interest in healthcare ETFs with sizable exposure to the company.
